跳至主要内容
临床试验/ACTRN12614000691640
ACTRN12614000691640尚未招募3 期

The effect of Upfront Administration of Fibrinogen concentrate on total blood volume loss in Obstetric Haemorrhage – A Pilot study

Auckland City Hospital0 个研究点目标入组 245 人开始时间: 2014年7月1日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
245

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
Female

入选标准

  • Insure both criteria 1) and 2) are satisfied;
  • 1.Women with estimated blood loss greater than 1000mL in the immediate postpartum period (<4 hours postpartum).
  • 2.Women with persistent PPH not responding to first line uterotonic therapy (i.e. syntocinon infusion), and manual uterine compression in whom further haemostatic intervention is being considered.

排除标准

  • Exclusion criteria
  • 1)Women with coagulopathic disorder secondary to pre-existing liver disease.
  • 2)Women with confirmed venous thromboembolism occurring in the last 4 weeks of pregnancy
  • 3)Women with confirmed allergy to fibrinogen concentrate
  • 4)Woman who refuse blood products

研究者

相似试验